Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-20 · accession 0001493152-21-032038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-20 | 2021-12-20 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $5.00 | +2,500 | 902.5K | +0.3% | +$12.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | P | A | 2,500 | $5.00 | 902,500 | D | — | — |